EVELO BIOSCIENCES (UK) LIMITED
Company overview
- Incorporation date
- 1 April 2019
- Company type
- Private limited company
- Jurisdiction
- England/Wales
- Can file
- Yes
Insolvency notices
-
17 September 2026
Notice of Intended Dividends
Read the notice →
Contains data from The Gazette, published under the Open Government Licence v3.0.
What the records show
EVELO BIOSCIENCES (UK) LIMITED is a private limited company incorporated on 1 April 2019, with its registered office in Kent. Companies House lists its business as other human health activities. Its most recent accounts were made up to 31 December 2022. Its next accounts, due by 30 September 2024, are overdue. Its confirmation statement, due by 15 April 2025, is overdue.
On 17 September 2026 The Gazette published a notice headed “Notice of Intended Dividends”.
In the 12 months before its first insolvency notice, Companies House recorded a change of registered office on 16 September 2026. It has 1 serving director.
Drawn only from the company's Gazette notices and its Companies House record. It records what was filed and published, not why.
Registered office address
2nd Floor Maritime Place Quayside, Chatham Maritime, Kent, ME4 4QZ
Industry classification (SIC codes)
Officers & directors (6)
JALBERT, Craig
Director
Appointed: 22 November 2023
ABEL, Stuart Michael, Dr
Director
Appointed: 27 March 2020 • Resigned: 3 May 2023
CHAR, Daniel Scott
Director
Appointed: 1 April 2019 • Resigned: 18 November 2022
MCHALE, Duncan Philip, Dr
Director
Appointed: 1 April 2019 • Resigned: 22 November 2023
POOLE, Jonathan Michael
Director
Appointed: 1 April 2019 • Resigned: 27 March 2020
THORELL, Marella Atwood
Director
Appointed: 18 November 2022 • Resigned: 22 November 2023
Recent filing history (33)
Liquidators' statement of receipts and payments to 23 July 2026
Insolvency • Form LIQ03
Registered office address changed from 2nd Floor 168 Shoreditch High Street London E1 6RA to 2nd Floor Maritime Place Quayside Chatham Maritime Kent ME4 4QZ on 16 September 2026
Address • Form AD01
Liquidators' statement of receipts and payments to 23 July 2025
Insolvency • Form LIQ03
Removal of liquidator by court order
Insolvency • Form LIQ10
Appointment of a voluntary liquidator
Insolvency • Form 600
Registered office address changed from 10 John Street London WC1N 2EB United Kingdom to 2nd Floor 168 Shoreditch High Street London E1 6RA on 5 August 2024
Address • Form AD01
Statement of affairs
Insolvency • Form LIQ02
Appointment of a voluntary liquidator
Insolvency • Form 600
Resolutions
Resolution • Form RESOLUTIONS
Compulsory strike-off action has been discontinued
Gazette • Form DISS40
Confirmation statement made on 1 April 2024 with no updates
Confirmation statement • Form CS01
First Gazette notice for compulsory strike-off
Gazette • Form GAZ1
Appointment of Mr Craig Jalbert as a director on 22 November 2023
Officers • Form AP01
Termination of appointment of Marella Atwood Thorell as a director on 22 November 2023
Officers • Form TM01
Termination of appointment of Duncan Mchale as a director on 22 November 2023
Officers • Form TM01
Persons with significant control (1)
Evelo Biosciences, Inc.
Corporate entity
Notified: 1 April 2019
Insolvency history
Creditors voluntary liquidation
Commencement of winding up: 24 July 2024
Practitioners:
Andrew John Tate - 2nd Floor Maritime Place Quayside
James Hopkirk - 2nd Floor, 168 Shoreditch High Street
Carrie James - 2nd Floor 168 Shoreditch High Street
Is your website working as hard as your Companies House record?
Get a free website audit from an SEO consultant with 27 years' experience.
Get free auditFiling status
Accounts
Next due: 30 September 2024
OVERDUEConfirmation statement
Next due: 15 April 2025
OVERDUE